• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Supriya Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75656.0
  • ISIN : INE07RO01027
656.80 -4 (-0.67%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    655.00

  • Today’s High

    665.00

  • Open

    660.20

  • Perv Close

    661.25

  • 52W Low

    384.10

  • 52W High

    842.00

Key Indicators

  • P/E(TTM)

    28.13

  • Mar.Cap (₹Cr.)

    5,286.11

  • Div & Yield %

    0.15

  • Book Value(₹)

    123.85

  • Debt-Equity Ratio

    -0.67

  • AGM Date

    01-Aug-2025

  • EPS

    23.35

  • P/E Ratio

    28.13

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    5,286.11

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.10

  • BV (₹)

    123.80

  • Sales( ₹ in Cr.)

    696.49

  • NP (in Cr.)

    187.96

  • NP Var(%)

    58.0

  • Div%

    50.0

  • CPS (₹)

    25.90

  • EPS (₹)

    23.40

  • Traded Value (₹ in Lakhs)

    5,287.32

  • 52 Week High

    842.00

  • 52 Week Low

    384.10

  • Price BSE

    657.0

  • Price NSE

    657.00

  • Market Capital( in Cr.)

    5,287.32

  • P/C Ratio

    25.40

  • P/E Ratio

    28.10

  • Price Vs.BV

    23.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 646.96 516.47 588.52 430.97 311.64 321.28
Excise Duty 76.59 55.53 58.47 39.76 0.00 43.44
Net Sales 570.37 460.94 530.05 391.21 311.64 277.84
Other Income 10.64 9.49 7.58 5.01 11.07 8.02
Stock Adjustments -30.31 6.51 3.03 12.44 13.90 -0.80
Total Income 550.70 476.94 540.66 408.66 336.61 285.06
EXPENDITURE :            
Raw Materials 191.43 187.32 198.83 140.57 152.38 146.07
Power and Fuel Cost 21.37 20.95 14.07 9.24 8.97 0.00
Employee Cost 67.64 55.58 49.08 32.76 18.88 0.00
Other Manufacturing Expenses 34.38 28.87 18.44 13.15 8.27 0.00
Selling and Administration Expenses 39.43 37.32 33.83 31.88 30.10 0.00
Miscellaneous Expenses 9.80 8.51 4.84 2.92 8.56 0.00
Employee Benefit Expenses 67.64 55.58 49.08 32.76 18.88 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 364.04 338.55 319.09 230.51 227.15 212.30
Operating Profit 186.65 138.38 221.56 178.15 109.45 72.76
Interest 5.15 3.08 4.20 4.08 6.85 10.22
Gross Profit 181.50 135.30 217.36 174.07 102.60 62.54
Depreciation 15.81 11.82 10.12 6.76 6.41 5.44
Profit Before Tax 165.69 123.48 207.24 167.31 96.19 57.10
Current Tax 37.10 30.68 52.19 43.02 25.07 17.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 9.48 2.95 3.25 0.69 -2.23 0.68
Reported Net Profit 119.11 89.86 151.81 123.59 73.35 39.42
Extraordinary Items 0.00 -0.08 0.00 0.00 0.00 0.00
Adjusted Net Profit 119.11 89.94 151.81 123.59 73.35 39.42
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -3.36 -0.29
P & L Balance brought forward 486.16 401.13 253.72 134.08 79.08 40.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.83 4.83 4.39 3.96 14.64 0.00
P & L Balance carried down 600.45 486.16 401.13 253.72 134.43 79.15
Dividend 0.00 0.00 0.00 0.00 14.64 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 30.00 30.00 27.00 100.00 0.00
Dividend Per Share(Rs) 0.80 0.60 0.60 0.54 10.00 0.00
Earnings Per Share-Unit Curr 14.80 11.16 18.86 16.89 50.11 5.39
Earnings Per Share(Adj)-Unit Curr 14.80 11.16 18.86 - - -
Book Value 101.31 86.91 76.50 36.70 101.84 12.82
Book Value(Adj)-Unit Curr 101.31 86.91 76.50 - - -

Shareholding Pattern

  • Promoter Group

    68.30%

  • Public Share Holding

    31.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10 0.00 10 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,967,815 68.30 54,967,815 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,967,825 68.30 54,967,825 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,456,154 6.78 5,456,154 74
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,871,593 2.33 1,871,593 2
Mutual Funds / UTI 547,103 0.68 547,103 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,493,058 1.86 1,493,058 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,367,908 11.64 9,367,908 94
2] Non Institution
Bodies Corporate 1,164,826 1.45 1,164,826 379
Clearing Members 1,385 0.00 1,385 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 931,323 1.16 931,323 2,025
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 691,544 0.86 691,544 1,344
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 712,343 0.89 712,343 3
Individuals holding nominal share capital up to Rs. 1 lakh 12,479,513 15.51 12,479,513 88,011
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 675 0.00 675 3
Others 0 0.00 0 0
Sub Total 16,147,067 20.06 16,147,067 91,828
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 80,482,800 100.00 80,482,800 91,928

Company Background

Supriya Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Supriya Lifescience Ltd
  • BSE Code : 75656.0
  • ISIN : INE07RO01027

  • Incorporation Year

    2008

  • Registered Office

    207/208 Udyog Bhavan
    Sonawala Road Goregaon (East), Mumbai,
    Maharashtra-400063

  • Telephone

    91-22-40332727

  • FAX

  • Chairman

    Satish Waman Wagh

  • Managing Director

    Shivani Satish Wagh

  • Company Secretary

    Prachi Sathe

  • Auditor

    Kakaria & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Supriya Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Supriya Lifesci. 656.95 581.01 646.96 28.13 22.05
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10